Orthodontic clinic, public dental health, Karlshamn, Region Blekinge, Sweden.
Novozymes A/S, Bagsværd, Denmark.
Eur J Orthod. 2023 Feb 10;45(1):96-102. doi: 10.1093/ejo/cjac062.
Mouthwashes containing oral antiseptics or enzymes are suggested suitable for controlling biofilm accumulation in patients with fixed appliances and thereby limiting unwanted side effects during the orthodontic treatment.
To evaluate the effect of an enzyme-based mouthwash on the amount of dental biofilm and the composition of the salivary microbiome in patients undergoing treatment with fixed orthodontic appliances.
Randomized double-blind placebo-controlled trial.
In total, 35 young adolescents (14-18 years) under treatment with fixed appliances were consecutively enrolled and randomly allocated to an experimental or a placebo group by opening a computer-generated numbered envelope. The subjects were instructed to rinse twice daily during an intervention period of 8 days with experimental mouthwash or placebo without active enzymes. Unstimulated whole saliva samples were collected at baseline and after 8 days. The participants and examiner were blinded for the allocation. The primary outcome was the Orthodontic Plaque Index (OPI) and the secondary was the composition of the salivary microbiome.
In total, 28 adolescents (21 females and 7 males) completed the trial and there were no differences in age, clinical, or microbial findings between the test (n = 14) and the placebo group (n = 14) at baseline. We found a decreased OPI in the test group after 8 days and the difference was statistically significant compared with the placebo group (P < 0.05). There were no significant treatment effects on the richness and global composition of the salivary microbiome.
In total, one participant in the test group claimed nausea and abandoned the project. In total, two participants did not like the taste of the mouthwash but used it as instructed. No other adverse events or side effects were reported.
Short-term pilot trials may by nature be sensitive for selection and performance biases and are not designed to unveil persisting effects.
Daily use of enzyme-containing mouthwash reduced the amount of dental biofilm in adolescents under treatment with the fixed orthodontic appliances, without affecting the composition of the salivary microbiota.
Approved by the Regional Ethical Board, Lund, Sweden (Dnr 2020-05221).
NCT05033015.
含有口腔抗菌剂或酶的漱口水被认为适用于控制固定矫治器患者的生物膜积聚,从而限制正畸治疗过程中的不良副作用。
评估基于酶的漱口水对接受固定正畸矫治器治疗的患者的牙菌斑数量和唾液微生物组组成的影响。
随机双盲安慰剂对照试验。
共纳入 35 名 14-18 岁接受固定矫治器治疗的青少年,并通过打开计算机生成的编号信封进行连续随机分组到实验组或安慰剂组。受试者被指示在 8 天的干预期间每天用实验组漱口水或无活性酶的安慰剂漱口两次。在基线和 8 天后采集未刺激的全唾液样本。参与者和检查者对分组情况均不知情。主要结局指标是正畸菌斑指数(OPI),次要结局指标是唾液微生物组的组成。
共有 28 名青少年(21 名女性和 7 名男性)完成了试验,在年龄、临床和微生物学方面,试验组(n=14)和安慰剂组(n=14)在基线时没有差异。我们发现实验组在 8 天后 OPI 降低,与安慰剂组相比差异有统计学意义(P<0.05)。治疗对唾液微生物组的丰富度和全局组成没有显著影响。
共有 1 名实验组参与者报告恶心并放弃了该项目。共有 2 名参与者不喜欢漱口水的味道,但按要求使用了它。没有其他不良事件或副作用报告。
短期的试点试验可能由于选择和表现偏差而变得敏感,并且不能揭示持续的影响。
在接受固定正畸矫治器治疗的青少年中,每天使用含酶漱口水可减少牙菌斑的数量,而不会影响唾液微生物群的组成。
经瑞典隆德地区伦理委员会批准(Dnr 2020-05221)。
NCT05033015。